We are live on
!
Find out more
CWA
Carolina Wealth Advisors Portfolio holdings
AUM
$255M
1-Year Est. Return
17.72%
This Fund
S&P 500
This Quarter
Est. Return
-0.64%
1 Year Est. Return
+17.72%
3 Year Est. Return
+57.55%
5 Year Est. Return
+71.59%
10 Year Est. Return
–
AUM
$158M
AUM Growth
-$18.6M
(-11%)
Cap. Flow
-$12.1M
Cap. Flow
% of AUM
-7.62%
Top 10 Holdings %
Top 10 Hldgs %
49.08%
Holding
311
New
26
Increased
89
Reduced
18
Closed
20
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Jefferies Financial Group
JEF
|
+$3.71M |
| 2 |
Ericsson
ERIC
|
+$3.28M |
| 3 |
Buckle
BKE
|
+$764K |
| 4 |
Schwab US TIPS ETF
SCHP
|
+$749K |
| 5 |
CTRA
Coterra Energy
CTRA
|
+$538K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Pfizer
PFE
|
+$6.63M |
| 2 |
NVO
Novo Nordisk
NVO
|
+$5.12M |
| 3 |
Automatic Data Processing
ADP
|
+$4.44M |
| 4 |
AT&T
T
|
+$2.88M |
| 5 |
Infosys
INFY
|
+$2.1M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 20.24% |
| 2 | Financials | 14.42% |
| 3 | Healthcare | 10.46% |
| 4 | Industrials | 5.31% |
| 5 | Energy | 4.99% |
Similar funds
CIM
JFG
PIP
WFP
2
LRIC
GAMC
TIA
Carolina Wealth Advisors's Q1 2022 Portfolio in Review
As of Q1 2022, Carolina Wealth Advisors held 311 positions worth $158M, down 11% from $177M the previous quarter. Its ten largest holdings account for 49% of the portfolio.
Carolina Wealth Advisors withdrew a net $12.1M in Q1 2022, closing 20 positions and reducing 18 holdings. Its most notable exit was Novo Nordisk, an estimated $5.12M position sold in full.
By sector, the portfolio is most concentrated in Technology at 20% of assets, down from 23% a quarter earlier, followed by Financials and Healthcare.
Against the trend, Carolina Wealth Advisors opened a new position in Buckle worth $682K.
- Carolina Wealth Advisors's largest Q1 2022 buy was Buckle: 20,629 shares worth $682K.
- Carolina Wealth Advisors added most to Jefferies Financial Group in Q1 2022, an estimated $3.71M increase.
- Carolina Wealth Advisors's biggest Q1 2022 reduction was Pfizer, cutting an estimated $6.63M.
- Carolina Wealth Advisors fully exited Novo Nordisk in Q1 2022, selling an estimated $5.12M.
- Carolina Wealth Advisors's ten largest holdings make up 49% of its $158M portfolio in Q1 2022.
- Carolina Wealth Advisors opened 26 new positions and closed 20 in Q1 2022.
- Carolina Wealth Advisors's portfolio value fell 11% quarter-over-quarter to $158M.
Based on Carolina Wealth Advisors's 13F filing for Q1 2022, filed 18 Apr 2022.